Use of CRF antagonists to treat circadian rhythm disorders
US6432989B1 · kind B1 · utility
8Cited by
4References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 5, 2000 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Jun 5, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A corticotropin releasing factor (CRF) antagonist is administered to treat disorders that can be treated by altering circadian rhythm.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.